Ludovica Ceci

发表

Amelioration of Ductular Reaction by Stem Cell Derived Extracellular Vesicles in MDR2 Knockout Mice via Lethal‐7 microRNA

S. Glaser, J. Venter, G. Alpini, 2019, Hepatology.

Cyclic AMP Signaling in Biliary Proliferation: A Possible Target for Cholangiocarcinoma Treatment?

S. Glaser, G. Alpini, Keisaku Sato, 2021, Cells.

Cholangiocarcinoma: bridging the translational gap from preclinical to clinical development and implications for future therapy

S. Chakraborty, A. Franchitto, S. Glaser, 2020, Expert opinion on investigational drugs.

Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development

S. Chakraborty, S. Glaser, G. Alpini, 2022, Cancers.

The functional roles of immune cells in primary liver cancer.

S. Chakraborty, S. Glaser, G. Alpini, 2022, The American journal of pathology.

Knockdown of vimentin reduces mesenchymal phenotype of cholangiocytes in the Mdr2−/− mouse model of primary sclerosing cholangitis (PSC)

S. Glaser, G. Alpini, Chaodong Wu, 2019, EBioMedicine.

Mast Cells Promote Nonalcoholic Fatty Liver Disease Phenotypes and Microvesicular Steatosis in Mice Fed a Western Diet

S. Glaser, G. Alpini, F. Meng, 2021, Hepatology.

The Effects of Taurocholic Acid on Biliary Damage and Liver Fibrosis Are Mediated by Calcitonin-Gene-Related Peptide Signaling

S. Chakraborty, R. Mancinelli, A. Franchitto, 2022, Cells.

Downregulation of p16 decreases biliary damage and liver fibrosis in the Mdr2-/- mouse model of primary sclerosing cholangitis.

S. Glaser, G. Alpini, Chaodong Wu, 2020, Gene expression.

Modulation of the Tryptophan Hydroxylase 1/Monoamine Oxidase‐A/5‐Hydroxytryptamine/5‐Hydroxytryptamine Receptor 2A/2B/2C Axis Regulates Biliary Proliferation and Liver Fibrosis During Cholestasis

D. Zawieja, L. Fabris, S. Glaser, 2020, Hepatology.

Modulation of the TPH 1 / MAO-A / 5 HT / 5 HTR 2 A / 2 B / 2 C Axis Regulates Biliary Proliferation and Liver Fibrosis During Cholestasis

D. Zawieja, L. Fabris, S. Glaser, 2019 .

FGF1 Signaling Modulates Biliary Injury and Liver Fibrosis in the Mdr2−/− Mouse Model of Primary Sclerosing Cholangitis

S. Chakraborty, S. Glaser, G. Carpino, 2022, Hepatology communications.

Possible application of melatonin treatment in human diseases of the biliary tract.

S. Glaser, G. Alpini, P. Kusumanchi, 2019, American journal of physiology. Gastrointestinal and liver physiology.

Kupffer cells: Inflammation pathways and cell-cell interactions in alcohol-associated liver disease.

S. Glaser, G. Alpini, Keisaku Sato, 2020, The American journal of pathology.

Kupffer Cells

S. Glaser, G. Alpini, Keisaku Sato, 2022 .

Pinealectomy or light exposure exacerbates biliary damage and liver fibrosis in cholestatic rats through decreased melatonin synthesis.

D. Zawieja, L. Fabris, S. Glaser, 2019, Biochimica et biophysica acta. Molecular basis of disease.

Knockout of α-calcitonin gene-related peptide attenuates cholestatic liver injury by differentially regulating cellular senescence of hepatic stellate cells and cholangiocytes

S. Glaser, J. Venter, G. Alpini, 2018, Laboratory Investigation.

Prolonged Administration of Melatonin Ameliorates Liver Phenotypes in Cholestatic Murine Model

R. Mancinelli, A. Franchitto, S. Glaser, 2022, Cellular and molecular gastroenterology and hepatology.

Secretin alleviates biliary and liver injury during late-stage primary biliary cholangitis via restoration of secretory processes.

A. Franchitto, S. Glaser, G. Carpino, 2022, Journal of hepatology.

REVIEW The Functional Roles of Immune Cells in Primary Liver Cancer

S. Chakraborty, S. Glaser, G. Alpini, 2022 .

The Emerging Role of Ferroptosis in Liver Cancers

R. Mancinelli, A. Franchitto, L. Pannarale, 2022, Life.

Knockout of the tachykinin receptor 1 in the Mdr2-/- mouse model of primary sclerosing cholangitis reduces biliary damage and liver fibrosis.

R. Mancinelli, A. Franchitto, S. Glaser, 2020, The American journal of pathology.

Knockout of secretin ameliorates biliary and liver phenotypes during alcohol-induced hepatotoxicity

S. Chakraborty, A. Franchitto, S. Glaser, 2023, Cell & Bioscience.

Functional Role of the Secretin/Secretin Receptor Signaling During Cholestatic Liver Injury

A. Franchitto, S. Glaser, G. Alpini, 2020, Hepatology.

Inhibition of Secretin/Secretin Receptor Axis Ameliorates NAFLD Phenotypes

S. Glaser, G. Alpini, Chaodong Wu, 2021, Hepatology.

Mast cells selectively target large cholangiocytes during biliary injury via H2HR‐mediated cAMP/pERK1/2 signaling

S. Glaser, G. Carpino, G. Alpini, 2022, Hepatology communications.

Mast cells in liver disease progression: An update on current studies and implications

S. Glaser, G. Alpini, Keisaku Sato, 2021, Hepatology.

p16 INK4A drives nonalcoholic fatty liver disease phenotypes in high fat diet fed mice through biliary E2F1/FOXO1/IGF-1 signaling

S. Glaser, G. Carpino, G. Alpini, 2023, Hepatology.

Melatonin receptor 1A, but not 1B, knockout decreases biliary damage and liver fibrosis during cholestatic liver injury

R. Mancinelli, A. Franchitto, S. Glaser, 2021, Hepatology.

Prolonged administration of a secretin receptor antagonist inhibits biliary senescence and liver fibrosis in Mdr2−/− mice

A. Franchitto, S. Glaser, G. Carpino, 2023, Hepatology.

Sa380 KNOCKDOWN OF P16 IMPROVES MAST CELL (MC)-MEDIATED BILIARY SENESCENCE AND NAFLD PHENOTYPES IN A DIET-INDUCED RODENT MODEL

G. Alpini, H. Francis, Lindsey Kennedy, 2021 .

Circadian Rhythm and Melatonin in Liver Carcinogenesis: Updates on Current Findings.

S. Glaser, G. Alpini, L. Baiocchi, 2021, Critical reviews in oncogenesis.

Endoplasmic reticulum stress: A possible connection between intestinal inflammation and neurodegenerative disorders

R. Mancinelli, A. Franchitto, L. Pannarale, 2024, Neurogastroenterology and motility.

Cellular Interactions and Crosstalk Facilitating Biliary Fibrosis in Cholestasis

Ludovica Ceci, Eugenio Gaudio, Lindsey Kennedy, 2024, Cellular and molecular gastroenterology and hepatology.